Novo Nordisk Owner to Open Obesity Drug Incubators Across Europe
The primary owner of Ozempic maker Novo Nordisk A/S is launching a network of research incubators across Europe, seeking to create breakthrough obesity and diabetes treatments by turning academic discoveries...
By Sanne Wass · Bloomberg
The primary owner of Ozempic maker Novo Nordisk A/S is launching a network of research incubators across Europe, seeking to create breakthrough obesity and diabetes treatments by turning academic discoveries into commercial ventures.